This article considers the potential impact for the international pharmaceutical and biotechnology industries of decisions from a US and a UK court given within a week of each other in October 2004. More
The Indian pharmaceutical market is due for a paradigm shift on January 1st 2005, when the country falls into line with the World Trade Organisation's TRIPs (Trade-Related aspects of Intellectual Property rights) agreement. More
The 'Harvard Oncomouse' patent claimed a method for producing transgenic non-human mammals with a predisposition to developing cancer. The prospect of the commercialisation of animals fated to develop cancer was the cause of significant protest. More
The University of California at San Francisco claims credit for identification of the DNA of the human growth hormone. Genentech was alleged to have taken and used the University's actual DNA invention without permission. More
Scientific progress depends on the publication of results while industry needs patents to protect its investment, what happens when these two worlds meet? More
Patinnova and Epidos brought together entrepreneurs, industrialists and patent professionals providing a vigorous exchanges of views to give fresh evidence of the central but controversial role of IP in the 'new economy'. More
Displaying 1..10 of 13 -
per page
Next page
Order by